middle.news
How Clarity’s New Copper-67 Deal Could Transform Prostate Cancer Treatment
9:36am on Thursday 16th of October, 2025 AEDT
•
Healthcare
Read Story
How Clarity’s New Copper-67 Deal Could Transform Prostate Cancer Treatment
9:36am on Thursday 16th of October, 2025 AEDT
Key Points
Three-year copper-67 supply agreement signed with Nusano
Nusano’s Utah facility to start production mid-2026
Supports Clarity’s Phase III trial for Cu-SAR-bisPSMA
Accelerator-based production offers scalable, sustainable supply
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clarity Pharmaceuticals (ASX:CU6)
OPEN ARTICLE